Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2019-03-14
2020-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biochemical Versus Ultrasound Findings as Predictors of Fetal Loss in Cases of First Trimester Threatened Miscarriage
NCT03797508
Early Pregnancy Ultrasound Measurements and Prediction of First Trimester Pregnancy Loss.
NCT06540092
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
NCT02694198
Biochemical, 2D and 3D Ultrasonographic Predictors of Pregnancy Outcome in Women With Threatened Abortion
NCT06797557
Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital
NCT04174235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
16-24 weeks Pregnant womes
Pregnant Women at (16-24) weeks of gestation for mid trimester anomaly scan with one sonographic fetal soft marker or more.
Midtrimester anomaly scan
A detailed anomaly scan to detect soft markers at 16 to 24 weeks pregnancy
Fetal Karyotyping
Fetal karyotyping after birth to confirm chromosomal anomaly diagnosed clinically
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midtrimester anomaly scan
A detailed anomaly scan to detect soft markers at 16 to 24 weeks pregnancy
Fetal Karyotyping
Fetal karyotyping after birth to confirm chromosomal anomaly diagnosed clinically
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. singelton pregnancy.
Exclusion Criteria
2. Mental condition rendering the patients unable to understand the nature and scope of the study.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasmin Ahmed Bassiouny
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maha M Mossad, MD
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.